Copper(I)-Phosphine Polypyridyl Complexes: Synthesis, Characterization, DNA/HSA Binding Study, and Antiproliferative...

Area of Science:

• Inorganic Chemistry
• Medicinal Chemistry
• Biochemistry

Background:

• Copper complexes are explored for their potential as anticancer agents.
• Polypyridyl ligands are crucial in designing metal-based therapeutics.
• Phosphine ligands can modulate the properties of copper complexes.

Purpose of the Study:

• To synthesize and characterize novel copper(I)-phosphine polypyridyl complexes.
• To investigate the DNA binding modes and protein interactions of these complexes.
• To evaluate the in vitro cytotoxicity of the synthesized copper complexes against various tumor cell lines.

Main Methods:

• Synthesis of copper(I) complexes using mild reaction conditions.
• Characterization via elemental analysis, spectroscopy (NMR, UV-vis, IR), and mass spectrometry.
• DNA interaction studies using UV-vis titrations, thermal denaturation, circular dichroism, viscosity, and gel electrophoresis.
• Protein binding affinity determined by fluorescence spectroscopy.
• Cytotoxicity assays against human breast (MCF-7), lung (A549), prostate (DU-145), and non-tumor cell lines (V79-4, MRC-5).

Main Results:

• Copper(I)-phosphine polypyridyl complexes were successfully synthesized and characterized.
• Complexes exhibit intercalative binding to DNA and high affinity for human serum albumin.
• Cytotoxicity analyses revealed that the copper complexes are more potent than the planar ligands and cisplatin.
• A positive correlation between cytostatic activity and lipophilicity was observed.

Conclusions:

• Copper(I)-phosphine polypyridyl complexes represent a promising class of anticancer agents.
• Their mechanism of action involves DNA intercalation and interaction with proteins.
• The lipophilicity of these complexes influences their cytostatic efficacy.